← Leaderboards
John W. Schoggins
Rockefeller University
$10,987,205
Attributed
$10,987,205
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,987,205 · 6
By mechanism
DP1$5,736,208 · 1
DP2$2,633,343 · 1
R01$1,846,465 · 2
K01$629,043 · 1
F32$142,146 · 1
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Meike Dittmann$3,056,621
- Charles M. Rice$80,497,748
- Marina Caskey$39,777,285
- Jeffrey Victor Ravetch$66,226,718
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenesVirusInterferonsVirus DiseasesProteinsViralBiochemicalAntiviral AgentsResponseBiologicalMolecularBaseVirologyInfluenza A VirusGeneticCell Culture TechniquesGenetic ApproachNatural ImmunityAreaBiologyLife Cycle StagesResistanceIn Vitro
Grant awards (20)
Cell intrinsic antiviral immunity in diverse bats$454,726
R01 · FY2025 · AI · contact PI
Cell intrinsic antiviral mechanisms targeting human enteroviruses$454,541
R01 · FY2025 · AI · contact PI
A functional evolutionary genetic approach to combat viral infection$1,148,000
DP1 · FY2024 · AI · contact PI
A functional evolutionary genetic approach to combat viral infection$1,148,000
DP1 · FY2023 · AI · contact PI
Cell intrinsic antiviral mechanisms targeting human enteroviruses$468,599
R01 · FY2023 · AI · contact PI
A functional evolutionary genetic approach to combat viral infection$1,148,000
DP1 · FY2022 · AI · contact PI
Cell intrinsic antiviral mechanisms targeting human enteroviruses$468,599
R01 · FY2022 · AI · contact PI
A functional evolutionary genetic approach to combat viral infection$1,147,708
DP1 · FY2021 · AI · contact PI
A functional evolutionary genetic approach to combat viral infection$1,144,500
DP1 · FY2020 · AI · contact PI
Discovery of antiviral mechanisms in bats$248,343
DP2 · FY2016 · AI · contact PI
Interactions between type I and III interferon during resolution of HCV infection$102,087
K01 · FY2016 · DK · contact PI
Interactions between type I and III interferon during resolution of HCV infection$102,087
K01 · FY2015 · DK · contact PI
Discovery of antiviral mechanisms in bats$2,385,000
DP2 · FY2014 · AI · contact PI
Interactions between type I and III interferon during resolution of HCV infection$147,139
K01 · FY2014 · DK · contact PI
Interactions between type I and III interferon during resolution of HCV infection$147,139
K01 · FY2013 · DK · contact PI
Interactions between type I and III interferon during resolution of HCV infection$77,670
K01 · FY2012 · DK · contact PI
Interactions between type I and III interferon during resolution of HCV infection$52,921
K01 · FY2012 · DK · contact PI
The role of interferon-stimulated genes in antiviral immunity$50,474
F32 · FY2010 · DK · contact PI
The role of interferon-stimulated genes in antiviral immunity$46,826
F32 · FY2009 · DK · contact PI
The role of interferon-stimulated genes in antiviral immunity$44,846
F32 · FY2008 · DK · contact PI